Redefining C-Word Care: How Poly-MVA and Nutrient Therapies Are Changing the Survival Landscape
A New Era in Oncology: Hope Beyond the Standard Model
Hearing the word “cancer” is life-altering—especially when it’s followed by “stage IV.” Traditionally, patients have been offered aggressive, one-size-fits-all treatments like full-dose chemotherapy and radiation, often with debilitating side effects and limited long-term success. But now, emerging integrative oncology protocols are transforming outcomes and redefining what survival looks like.
One of the most promising innovations in this space? A mitochondrial-based compound called Poly-MVA, which—when used with low-dose chemotherapy and targeted nutrient therapy—is producing survival rates previously considered impossible in advanced cancer.
This is more than a treatment protocol. It’s a movement.
The Limitations of Chemotherapy Alone: A Hard Look at the Data
A widely cited study published in the Journal of Clinical Oncology assessed chemotherapy’s true impact on five-year survival in adult solid tumors. The conclusion was sobering:
-Australia: 2.3%
-United States: 2.1%
These numbers reflect survival directly attributed to chemotherapy, not to surgical intervention or early detection. The authors stated clearly:
Cytotoxic chemotherapy only makes a minor contribution to cancer survival.
While modern medicine has advanced in areas like targeted radiation and immunotherapy, the overall cancer mortality rate has remained largely static when adjusted for age. This gap between technological progress and actual patient outcomes demands a new approach—one that supports the body, not just attacks the tumor.
Poly-MVA + Low-Dose Chemotherapy: A Paradigm Shift
Leading this new wave is Dr. James Forsythe, a board-certified oncologist and integrative medicine specialist. At the Century Wellness Clinic in Reno, Nevada, Dr. Forsythe has treated over 1,700 stage IV cancer patients using a protocol that combines:
Low-dose chemotherapy (20% of standard dosing)
Poly-MVA
Targeted nutrient therapy
Clinical Results:
-5-Year Survival Rate: 71%
-Over 16 types of cancer treated, including:
-Breast
-Lung
-Colon
-Liver
-Glioblastoma
-Prostate
Patients not only lived longer, they lived better—with less toxicity, fewer side effects, and improved energy and vitality. This combination, known as “fractionated chemo with metabolic support,” represents one of the most hopeful and effective strategies in modern cancer care.
What Is Poly-MVA?
A Cellular-Level Game Changer
Poly-MVA stands for Poly - Minerals, Vitamins and Amino Acids and contains a proprietary blend of:
-Palladium alpha-lipoic acid complex (LAMC)
-Vitamins B1, B2, B12
-Molybdenum
-N-Acetyl Cysteine (NAC)
-Trace elements like Rhodium and Ruthenium
Poly-MVA targets the Mitochondria—the energy center of the cell to:
-Restore ATP (cellular energy) production
-Boost immune function
-Interrupt cancer metabolism
-Neutralize oxidative stress
Why This Matters:
Cancer cells thrive in low-oxygen, low-energy environments. Poly-MVA shifts the cellular environment by increasing redox potential and oxygenation, weakening cancer’s grip at the metabolic level.
Antioxidant Power: Poly-MVA’s ORAC Score and Beyond
ORAC (Oxygen Radical Absorbance Capacity) measures a compound’s ability to neutralize free radicals. Poly-MVA scores exponentially higher than most traditional antioxidants, including:
-Vitamin C
-Vitamin E
-Alpha-lipoic acid (alone)
-CoQ10
This makes it a front-line defender against oxidative stress, which plays a central role in cancer progression, inflammation, and treatment resistance.
Scientific Validation: What Lab Research Shows About Poly-MVA
Poly-MVA has been tested on multiple human cancer cell lines in independent laboratories.
2007 – KGK Synergize (Canada):
-Glioblastoma (U87, HT-80)
-Liver (Hep G2)
-Lung (Malme-3M)
-Colon (HT-29)
-Breast (MDA-MB 435)
-Prostate (LNCaP)
-Melanoma (SKMel-5)
Results:
-Up to 96.3% cancer cell death within 48 hours
-Minimal damage to healthy cells
-Mitochondrial and apoptotic (natural death) pathways activated
Follow-Up Study – Garnett McKeen Laboratory:
-Validated results using NCI-standard protocols, confirming cytotoxic effects in breast, ovarian, and lung cancer models.
-Poly-MVA + Radiation: Amplifying Treatment, Reducing Damage
-In clinical practice, Poly-MVA has been shown to enhance the effectiveness of radiation therapy while protecting healthy tissues from collateral damage.
Patients report:
-Less fatigue
-Faster post-radiation recovery
-Reduced skin irritation
-Improved white blood cell counts
The Underrated Power of Vitamin D in Cancer Prognosis
If there’s one nutrient consistently tied to cancer outcomes, it’s Vitamin D. Yet up to 85% of cancer patients have suboptimal levels of 25-hydroxyvitamin D [25(OH)D]—the only reliable marker for body stores.
> Low levels (<40 ng/mL) correlate with increased mortality in breast, colon, prostate, and lung cancers.
Why it Matters:
-Enhances T-cell and macrophage immune activity
-Suppresses tumor angiogenesis (blood supply)
-Improves insulin sensitivity and metabolic signaling
Test the Right Form:
DO test: 25(OH)D
DON’T rely on: 1,25(OH)2D (can appear normal even when deficient)
CelluShine Pro Tip:
Ensure daily dosing of D3 + K2 for synergistic calcium metabolism, especially in cancer patients.
Why Nutrition and Sugar Control Are Just as Crucial as Treatment
Cancer is not just a disease of mutations—it’s a disease of metabolism. Research shows that cancer cells prefer fructose and glucose as primary fuels.
Studies confirm:
-Cancer cells metabolize fructose more aggressively than glucose
-High insulin levels can accelerate tumor growth
-Integrative Nutrition Recommendations:
-Eliminate refined sugars and high-fructose corn syrup
-Adopt a low-glycemic, nutrient-dense diet
-Incorporate therapeutic compounds like:
NAC, Curcumin, Sulforaphane, Green tea extract
Real Stories, Real Survivors: When Integrative Oncology Saves Lives
“When I found Dr. Forsythe, I was given months to live. Six years later, I’m cancer-free and thriving. Poly-MVA and the protocol saved my life.”
— Sandra K., Breast Cancer Survivor
“The chemo nearly killed me. The integrative route gave me my life back—and with it, hope. My energy returned, and the cancer never did.”
— James L., Prostate Cancer Survivor
Visit the Poly MVA Survivors Website at: polymvasurvivors.org
Conclusion: Why the Future of Cancer Treatment Must Be Integrative
Poly-MVA is not an alternative to conventional cancer care—it’s an enhancement of it. By supporting mitochondrial function, enhancing chemotherapy response, and supplying the nutrients cancer patients desperately need, integrative oncology offers a path forward rooted in science, compassion, and results.
It’s time to move from destruction to restoration
Explore the Science. Experience the Difference: Poly MVA Plus
Use CODE to get 25% off: PRATH25
